Updated COVID-19 Vaccine Guidance | Immunocompromised

Updated COVID-19 Vaccine Guidance | Immunocompromised
05.04.2023

The CDC revised its mRNA COVID-19 vaccine schedule for people who are moderately or severely immunocompromised:

  • At the time of initial vaccination, people ages 6 months+ are recommended to receive 3 bivalent mRNA doses.

  • People ages 6 months+ who previously received only monovalent doses are recommended to receive 1 or 2 bivalent mRNA vaccine doses, depending on age and vaccine product.

  • People who previously received a bivalent mRNA vaccine dose(s) have the option to receive 1 or more additional bivalent mRNA doses.

For more on the new COVID-19 vaccine guidance, and other COVID-19 updates including the latest Omicron variant of interest XBB.1.16, watch the April 26 Provider Forum with Dr. Chris Ledtke. The resources referenced in Dr. Ledtke's talk can be found here.